Objectives The objective of this project is to generate pilot data substantiating our hypothesis that advanced body composition measurement tools will provide more accurate and clinically relevant data on the outcomes of metabolic surgery (MS) in patients with severe obesity compared to traditional methods. To achieve this objective, the investigators propose the following aims: Aim 1: Evaluate the effectiveness of different body composition measurement tools in assessing outcomes in patients with severe obesity undergoing MS. Aim 2: Assess the changes in body composition and muscle strength following MS. Aim 3: Compare body compositions changes between SG and RYGB patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Evaluate the effectiveness of Bioimpedance Analysis (BIA) in assessing outcomes in patients with severe obesity undergoing metabolic surgery (MS).
Timeframe: Baseline and 6 months
Evaluate the effectiveness of Leg Strength and Endurance Testing in assessing outcomes in patients with severe obesity undergoing MS.
Timeframe: Baseline and 6 months
Evaluate the effectiveness of BIA in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of BIA in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness Body MRI in assessing outcomes of body composition in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of BIA in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of anthropometric measurement tool in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of anthropometric measurement tool in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of BIA measurement tool in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of anthropometric measurement tools in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness Body MRI in assessing outcomes of body composition in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness Body MRI in assessing outcomes of body composition in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of Six-Minute Walk testing in assessing outcomes in patients with severe obesity undergoing MS.
Timeframe: Baseline and 6 months
Evaluate the effectiveness of 3D Optical Imaging in assessing outcomes in patients with severe obesity undergoing MS.
Timeframe: Baseline and 6 months
Evaluate the effectiveness of BodPod (Air Displacement Plethysmography) in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of BodPod in assessing outcomes in patients with severe obesity undergoing MS.
Timeframe: Baseline and 6 months
Evaluate the effectiveness of Dual Energy X ray Absorptiometry (DXA) in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of DXA in assessing outcomes in patients with severe obesity undergoing MS
Timeframe: Baseline and 6 months
Evaluate the effectiveness of Deuterium & Bromide Dilution in assessing outcomes in patients with severe obesity undergoing metabolic surgery (MS).
Timeframe: Baseline and 6 months
Evaluate the effectiveness of Deuterium & Bromide Dilution in assessing outcomes in patients with severe obesity undergoing MS.
Timeframe: Baseline and 6 months